Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumptionSabrina Bagaglio, Giulia Morsica, Caterina Uberti‐Foppa et al.|Infection|2011Cited by 12
Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/RibavirinSabrina Bagaglio, Giulia Morsica, Caterina Uberti‐Foppa et al.|Medicine|2015Cited by 11
Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients.Giulia Morsica, Caterina Uberti‐Foppa, Giampaolo Bianchi et al.|PubMed|2011Cited by 8
1195 TEMPORAL DYNAMIC OF MUTATIONS ASSOCIATED WITH HCV PROTEASE INHIBITORS RESISTANCE IN NATURAL STRAINS OF HIV/HCV COINFECTED INDIVIDUALSEmanuela Messina, Caterina Uberti‐Foppa, Giulia Morsica et al.|Journal of Hepatology|2012Cited by 0